SM-Youtube

Year	Number of Results
2004	1
2005	9
2006	11
2007	8
2008	15
2009	9
2010	17
2011	14
2012	22
2013	13
2014	8
2015	10
2016	3
2017	6
2018	10
2019	12
2020	9
2021	6
2022	2
2024	2

1

p38α mitogen-activated protein kinase inhibitors, a patent review (2005-2011).

Fischer S, Koeberle SC, Laufer SA. Fischer S, et al. Expert Opin Ther Pat. 2011 Dec;21(12):1843-66. doi: 10.1517/13543776.2011.636737. Epub 2011 Nov 15. Expert Opin Ther Pat. 2011. PMID: 22082194 Review.

2

MAPK phosphatase 1 inhibition of p38α within lung myofibroblasts is essential for spontaneous fibrosis resolution.

Fortier SM, Walker NM, Penke LR, Baas JD, Shen Q, Speth JM, Huang SK, Zemans RL, Bennett AM, Peters-Golden M. Fortier SM, et al. J Clin Invest. 2024 Mar 21;134(10):e172826. doi: 10.1172/JCI172826. J Clin Invest. 2024. PMID: 38512415 Free PMC article.

3

Current status and future prospects of p38α/MAPK14 kinase and its inhibitors.

Madkour MM, Anbar HS, El-Gamal MI. Madkour MM, et al. Eur J Med Chem. 2021 Mar 5;213:113216. doi: 10.1016/j.ejmech.2021.113216. Epub 2021 Jan 22. Eur J Med Chem. 2021. PMID: 33524689 Review.

4

Inhibitory effect of p38 mitogen-activated protein kinase inhibitors on cytokine release from human macrophages.

Smith SJ, Fenwick PS, Nicholson AG, Kirschenbaum F, Finney-Hayward TK, Higgins LS, Giembycz MA, Barnes PJ, Donnelly LE. Smith SJ, et al. Br J Pharmacol. 2006 Oct;149(4):393-404. doi: 10.1038/sj.bjp.0706885. Epub 2006 Sep 4. Br J Pharmacol. 2006. PMID: 16953188 Free PMC article.

5

Inhibiting MAPK14 showed anti-prolactinoma effect.

Ding QY, Zhang Y, Ma L, Chen YG, Wu JH, Zhang HF, Wang X. Ding QY, et al. BMC Endocr Disord. 2020 Sep 7;20(1):138. doi: 10.1186/s12902-020-00619-z. BMC Endocr Disord. 2020. PMID: 32894113 Free PMC article.

6

3D-QSAR and molecular docking analysis of biphenyl amide derivatives as p38α mitogen-activated protein kinase inhibitors.

Ambure PS, Gangwal RP, Sangamwar AT. Ambure PS, et al. Mol Divers. 2012 May;16(2):377-88. doi: 10.1007/s11030-011-9353-y. Epub 2012 Jan 7. Mol Divers. 2012. PMID: 22228035

7

Molecular modeling of p38α mitogen-activated protein kinase inhibitors through 3D-QSAR and molecular dynamics simulations.

Chang HW, Chung FS, Yang CN. Chang HW, et al. J Chem Inf Model. 2013 Jul 22;53(7):1775-86. doi: 10.1021/ci4000085. Epub 2013 Jul 10. J Chem Inf Model. 2013. PMID: 23808966

8

MAP kinase p38 inhibitors: clinical results and an intimate look at their interactions with p38alpha protein.

Lee MR, Dominguez C. Lee MR, et al. Curr Med Chem. 2005;12(25):2979-94. doi: 10.2174/092986705774462914. Curr Med Chem. 2005. PMID: 16378500 Review.

9

p38 alpha mitogen-activated protein kinase inhibition improves cardiac function and reduces myocardial damage in isoproterenol-induced acute myocardial injury in rats.

Li Z, Tran TT, Ma JY, O'Young G, Kapoun AM, Chakravarty S, Dugar S, Schreiner G, Protter AA. Li Z, et al. J Cardiovasc Pharmacol. 2004 Oct;44(4):486-92. doi: 10.1097/01.fjc.0000141474.06383.6f. J Cardiovasc Pharmacol. 2004. PMID: 15454858

10

Tetra-substituted pyridinylimidazoles as dual inhibitors of p38α mitogen-activated protein kinase and c-Jun N-terminal kinase 3 for potential treatment of neurodegenerative diseases.

Muth F, Günther M, Bauer SM, Döring E, Fischer S, Maier J, Drückes P, Köppler J, Trappe J, Rothbauer U, Koch P, Laufer SA. Muth F, et al. J Med Chem. 2015 Jan 8;58(1):443-56. doi: 10.1021/jm501557a. Epub 2014 Dec 5. J Med Chem. 2015. PMID: 25475894

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

166 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Search Results

166 results

Results by year